Journal article
Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES). CASES Investigators.
- Abstract:
-
BACKGROUND: Intravenous recombinant tissue plasminogen activator (tPA, alteplase) was conditionally licensed for the treatment of acute ischemic stroke (AIS) in Canada on February 17, 1999. As a condition of licensure, the Canadian Activase for Stroke Effectiveness Study (CASES) was established to monitor the use of alteplase for AIS in Canada. The study involves multiple stakeholders. METHODS: CASES is a prospective registry of patients treated with alteplase for AIS. The purposes of this re...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
- Volume:
- 28
- Issue:
- 3
- Pages:
- 232-238
- Publication date:
- 2001-08-01
- ISSN:
-
0317-1671
- Source identifiers:
-
79341
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:79341
- UUID:
-
uuid:f8d47627-fb41-4623-a258-0381a7811414
- Local pid:
- pubs:79341
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2001
If you are the owner of this record, you can report an update to it here: Report update to this record